NEW YORK — Infectious endophthalmitis after intravitreal dexamethasone implant is rare but more frequent than after anti-VEGF injections, according to a poster presented at the American Society of Retina Specialists annual meeting.
Konstantin Astafurov, MD, PhD, and co-authors retrospectively reviewed the data of patients treated with the dexamethasone (DEX) implant between January 2015 and April 2021; 5,420 implants were administered to 1,591 patients. Indications were retinal vein occlusion, diabetic macular edema and Irvine-Gass syndrome.
Infectious endophthalmitis (IE) developed in